The largest database of trusted experimental protocols

Fitc anti cd63

Manufactured by BD
Sourced in United States

FITC anti-CD63 is a fluorescently labeled antibody that binds to the CD63 protein. CD63 is a transmembrane glycoprotein commonly used as a marker for exosomes and other extracellular vesicles.

Automatically generated - may contain errors

4 protocols using fitc anti cd63

1

Basophil Activation Test for Peanut Allergy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Basophil activation tests (BAT) were performed using the Flow CAST Basophil Activation Test kit (Bühlmann Laboratories, Schönenbuch, Switzerland). 50 μl aliquots of whole blood from peanut allergic patients were pre incubated with 125-1000 μg/ml of purified IgA for 2-4 hours at 37°C in 100 μl of basophil stimulation buffer. Samples were incubated for l5 min at 37°C with 3.6x10-4 μg/ml of crude peanut extract (CPE) and staining antibodies for human PE anti-CCR3 (Biolegend, San Diego, CA) and FITC anti-CD63 (BD Biosciences, Franklin Lakes, NJ). Anti-FcϵRI stimulation was used as a positive control for basophil activation. After red blood cell lysis, cells were washed and assessed for activation by flow cytometry. Basophils were identified as SSClowCCR3+ and activated cells identified based on CD63 expression. Around 200 basophils were evaluated for each sample. Peripheral blood from peanut allergic donors was obtained with informed consent under a protocol approved by the Institutional Review Board of Boston Children’s Hospital.
+ Open protocol
+ Expand
2

Monoclonal Antibody Characterization for Fel d 1 Allergy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The monoclonal Fel d 1-specific IgE and IgG antibodies used in these experiments have been described previously (14) . They have been genetically engineered to be expressed as either human or mouse antibodies and were produced in CHO cells (Evitria AG, Zürich, Switzerland) and purified by affinity chromatography over a protein L or protein G Sepharose column (GE Healthcare) respectively. The monoclonal Fel d 1-specific IgE F127 was chosen for subsequent activation and binding assays in this study. For activation assays, the mast cells were stained with FITC anti-CD63 (BD Bioscience, NJ, USA) antibodies. Marker expressions were assessed with APC anti-c-kit (Biolegend, San Diego, CA, USA), PE anti-FcεRI (Biolegend) and IgE binding with APC anti-IgE (Miltenyi Biotec, Bergisch Gladbach, Germany). Mast cell binding of Fel d 1 was assessed by staining with the FITC-labelled monoclonal mouse anti-Fel d 1 IgG recognizing the non-overlapping epitope G078 (14) .
+ Open protocol
+ Expand
3

Exosome Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exosomes were isolated using a multi-step process. Large vesicles were eliminated by sequential centrifugation up to 50,000g as described12 (link). The remaining particles were pelleted by ultracentrifugation (Sorvall mTx 150, Thermo Scientific, Springfield, NJ) at 100,000g for 18 h. Vesicles expressing CD63 were immunoselected using CD63 magnetic bead isolation. The recovered particle size was verified by nanoparticle tracking analysis (NTA) using a NanoSight NS300 instrument (Amesbury, UK) as described11 (link). The data were analyzed with the NTA software (NANOSight version 2.3) using dilutions with deionized water. Three videos at a minimum of 200 completed tracks were collected at 30-s time intervals/video per sample.
Exosomes were further distinguished by flow cytometry with magnetic beads coupled to anti-CD9-PE, anti-CD63-FITC and anti-ALIX-APC (BD Biosciences).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single‐cell suspensions were analysed by a BD FACS Canto II flow cytometer equipped with 488, 633, and 405 nm lasers using FACS Diva software (Becton Dickinson, Franklin Lakes, NJ, USA) as described before (Berger et al, 2014). Propidium iodide (PI) and apoptosis stainings were performed as described previously (Berger et al, 2014) and according to manufacturer's instructions (Annexin V Apoptosis Detection Kit eFluor® 450, 88‐8006; eBioscience, San Diego, CA, USA). eGFP+ or mCherry+ KU812 cells were high‐purity FACS sorted on a FACS Aria III equipped with a 488 nm laser at 4°C (Becton Dickinson). Exosomes were stained with anti‐CD63‐FITC (561924; BD Biosciences) and anti‐CD81‐APC (561958; BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!